Clinical Trial to Evaluate the Hair Loss Prevention, Hair Growth Effect, and Safety of HDMHG0401-10 in Patients with Androgenic Alopecia

This study reported that the topical treatment HDMHG0401-10 significantly improved hair density in men with androgenetic alopecia compared to placebo, although subjective hair growth ratings were not significantly different.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

In this randomized controlled trial, the topical application of a PGA solution significantly increased hair density in patients with androgenetic alopecia compared to placebo, with no adverse reactions reported over 24 weeks, suggesting its potential as a safe and effective treatment option.

This study found that Scalp med®, a solution including minoxidil, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.

This study reports that topical 5% minoxidil solution significantly increased total hair counts and hair diameter in Korean men with androgenetic alopecia over 24 weeks and was well tolerated.